Dexdomitor
Dexdomitor is a veterinary anesthetic medication developed by Zoetis. It is a potent sedative and analgesic agent used in various animal species for the purpose of inducing a state of relaxation and pain relief during medical procedures.
Lab products found in correlation
28 protocols using dexdomitor
Anesthesia Protocol for Canine Imaging
Feline Anesthetic Comparison Protocol
PET Imaging of Glucose Metabolism in Rats
Functional Connectivity in Aged Rat Brain
The rats were food-deprived for a minimum of 12 h before starting the procedures. Anesthesia was induced with isoflurane (5%; Sofloran; PiSA) enriched with oxygen for 5 min. Once the animals were unresponsive, dexmedetomidine was administered (subcutaneous; Dexdomitor; Zoetis, 0.007 mg/kg) and the rats were placed in the scanner with the head fixed and maintained with isoflurane (0.25–0.50%) during the scanning session. Heart rate, breath rate, and spO2 were monitored continuously to assess the depth of anesthesia and general physiological condition of the animals. Body temperature was maintained by circulating warm water within the animal holder.
Feline Gonadectomy Procedure Protocol
Anesthesia and Monitoring Protocol for Animal Experiments
Canine Cardiac SPECT Imaging Protocol
Anesthesia was induced 25 min after premedication, using 2–5 mg/kg propofol I.V. and maintenance with 2% isoflurane. SPECT acquisition started at 35–40 min after the radiopharmaceutical
injection.
Parkinson's Disease Mouse and Monkey Models
Carotid Sinus Nerve Labeling in Rats
Tick Infestation and Lyme Disease Detection
On days 48 and 49 (pre-treatment), blood samples were collected for the purpose of determining infection status of dogs using SNAP, Quant C6, and Lyme Multiplex assays. Additionally, two skin punch biopsies were collected from each dog in the dorsal cervical region, near the site where the ticks were released onto the animal. Biopsies were taken using a 4 mm punch biopsy under sedation using Dexdomitor® (dexmedetomidine hydrochloride; Zoetis) and Antisedan® (atipamezole hydrochloride; Zoetis) for reversal. The first punch biopsy was placed in Barbour-Stoenner-Kelly II (BSK II) medium for bacterial culture (data not shown) and the second was immediately frozen by placement on dry ice and stored at −20 °C until DNA isolation and PCR were performed as described [28 (link)].
Post-treatment blood samples for serum collection were obtained monthly (days 111, 145, 179, 221, 251, 281, 314) and post-treatment skin biopsies and PCR were performed on days 118, 146, 180 and at the end of the study on day 315.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!